XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues:      
Total net sales $ 2,971,956 $ 2,785,874 $ 2,365,365
Costs and operating expenses:      
Costs and operating expenses 1,248,182 1,156,533  
Selling and administrative expenses 658,026 626,968 553,698
Research and development expenses 176,190 168,358 140,777
Purchased intangibles amortization 6,366 7,143 10,587
Asset Impairments 0 0 6,945
Litigation provision (Note 11) 0 5,165 1,180
Acquired in-process research and development 9,797    
Total costs and operating expenses 2,098,561 1,964,167 1,719,876
Operating income 873,395 821,707 645,489
Other income (expense), net 2,228 17,203 (1,775)
Interest expense (48,797) (44,938) (49,070)
Interest income 11,020 12,221 16,270
Income before income taxes 837,846 806,193 610,914
Provision for income taxes 130,091 113,350 89,343
Net income $ 707,755 $ 692,843 $ 521,571
Net income per basic common share $ 11.8 $ 11.25 $ 8.4
Weighted-average number of basic common shares 59,985 61,575 62,094
Net income per diluted common share $ 11.73 $ 11.17 $ 8.36
Weighted-average number of diluted common shares and equivalents 60,331 62,028 62,414
Product [Member]      
Revenues:      
Total net sales $ 1,988,169 $ 1,822,070 $ 1,497,333
Costs and operating expenses:      
Costs and operating expenses 836,209 752,514 638,033
Service [Member]      
Revenues:      
Total net sales 983,787 963,804 868,032
Costs and operating expenses:      
Costs and operating expenses $ 411,973 $ 404,019 $ 368,656